tes introduced significant variability, leading to failed experiments and production failures. Zap-CHO addresses these concerns and provides significant benefits in CHO cell culture, including:
*Faster cell line development and seed train expansion
*Animal component-free media
*Consistency of a defined media component
*Biomanufacturing optimization and improved production economics
*Better and more predictable performance in cell culture research and development
Now, with Zap-CHO, customers can get the animal free benefit of hydrolysates, the performance of FBS and the consistency of a defined media, said Randy Semadeni, InVitrias Vice President of Business Development. It is a new era for the cell culture industry.
About InVitria - www.InVitria.com
InVitria develops, manufactures and markets a portfolio of high performance and well defined cell culture media components and reagents used in bioprocessing, biopharmaceutical formulation, stem cell & regenerative medicine, life science research, medical devices and diagnostics.
For more information about InVitrias products or to obtain a copy of Dr. Pettits Zap-CHO poster or presentation, please contact InVitria at info@invitria.com or call 1-800-916-8311.
'/>"/>Page: 1 2 Related biology news :1.
InVitria Successfully Completes Beta Testing and Announces Commercial Launch of Optiferrin for Mammalian Cell Culture2.
InVitria Sponsors ESACT 2009 in Dublin, Ireland3.
InVitria to Unveil Powerful Cell Culture Media Component ZAP-CHO4.
InVitria Announces Launch of Recombinant Albumin for Diagnostics5.
The BBVA Foundation presents its Frontiers of Knowledge Awards6.
Versartis presents positive preclinical data on 2 product candidates at ENDO 097.
REGiMMUNE presents enhanced efficacy data in preclinical transplantation models8.
Biolex presents Locteron US Phase 2a hepatitis C data at EASL9.
GSA special paper presents new studies of Western US earth motion10.
AIUM Presents 2009 Joseph H. Holmes Pioneer Awards11.
AIUM presents 2009 Memorial Hall of Fame awards